KIF18A and central nervous system cancer: KIF18A upregulation contributes to the malignant progression and unfavorable prognosis of various types of cancer, including breast, hepatocellular, clear cell renal, prostate, esophageal carcinomas, and lung adenocarcinoma, especially glioma [52,53,54,55,56,57,58,59,60,61].